Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implementing dosimetry in GATE: dose-point kernel validation with GEANT4 4.8.1.

Ludovic Ferrer1, Nicolas Chouin, Abdalkader Bitar

  • 1INSERM, U601, Nantes, France, Medical Physics Department, CRLCC Rene Gauducheau, Saint-Herblain, France. l-ferrer@nantes.fnclcc.fr

Cancer Biotherapy & Radiopharmaceuticals
|April 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dosimetric Feasibility of Dose-Painting Radiation Therapy for Targeting Hypoxia in Prostate Cancer on a Novel Ring Gantry Radiation Therapy System.

Advances in radiation oncology·2026
Same author

OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific Dosimetry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Temporal footprint reduction via neural network denoising in 177Lu radioligand therapy.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025
Same author

Establishing measurement traceability for quantitative SPECT imaging.

EJNMMI physics·2025
Same author

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.

European thyroid journal·2025
Same author

Rethinking Dosimetry: A European Perspective.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same journal

Review of Glypican-3-Targeted Imaging Agents for Hepatocellular Carcinoma.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Clinical Laboratory Evaluation of the Biodistribution of a Radiolabeled Antimicrobial Peptide for Precision Radiopharmaceutical-Guided Radionuclide Therapy in Severe Pneumonia Among Immunocompromised Patients with Cancer.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Single-Cell Transcriptomics in Triple-Negative Breast Cancer: Implications for Radionuclide Therapy in Precision Oncology.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Curved Vertebroplasty System Combined with Targeted Radionuclide Therapy for Tumor-Related Pathological Vertebral Fractures.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Development of a Freeze-Dried Bevacizumab Kit for <sup>99m</sup>Tc Radiolabeling and Preclinical Evaluation <i>In Vitro</i> and in Normal Mice.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Radionuclide-Based Theranostic Mapping for Spatially Optimized Treatment Planning in Cervical Carcinoma.

Cancer biotherapy & radiopharmaceuticals·2026
See all related articles

This study validated the integration of GEANT4

Area of Science:

  • Medical Physics
  • Computational Science

Background:

  • GATE is a Monte Carlo code used in nuclear medicine for imaging and detector design.
  • GEANT4, a foundational toolkit, offers advanced dosimetric capabilities.
  • Integrating these tools enhances simulation accuracy for nuclear medicine applications.

Purpose of the Study:

  • To implement and validate GEANT4's dosimetric capabilities within the GATE simulation framework.
  • To assess the accuracy of electron multiple scattering algorithms in GEANT4 for dosimetry.
  • To establish a foundation for advanced dose calculations in nuclear medicine simulations.

Main Methods:

  • Calculated dose point kernels (DPK) for monoenergetic electrons (0.01–3 MeV) using GEANT4.
  • Compared calculated DPKs with MCNPX and Berger and Seltzer's reference data.

Related Experiment Videos

  • Adjusted GEANT4 parameters (Stepmax, shell thickness) for improved accuracy below 1 MeV.

    • Main Results:

    • DPKs calculated using GEANT4 showed good agreement with reference data across various electron energies.
    • A Kolmogorov-Smirnov test indicated no significant differences for energies above 10 keV.
    • Parameter adjustments were necessary for accurate simulations at lower electron energies.

    Conclusions:

    • The preliminary validation supports the integration of GEANT4's dosimetric features into GATE.
    • This integration holds significant potential for improving dose calculations in nuclear medicine.
    • Further work can leverage these combined capabilities for advanced imaging and treatment planning.